AGRX - Agile Therapeutics EPS beats by $0.01 misses on revenue July, 26 2021 04:11 PM Agile Therapeutics Inc. Agile Therapeutics (AGRX): Q2 Non-GAAP EPS of -$0.21 beats by $0.01.Revenue of $1.2M (-14.3% Y/Y) misses by $0.33M.Shares +6.25%.Press Release For further details see: Agile Therapeutics EPS beats by $0.01, misses on revenue